BIO PREVIEW: Deficit hawks, cash cows: A fiery Chicago party
This article was originally published in Scrip
Executive Summary
While much of what draws biotechs and big pharmas to the BIO International Conference are the one-on-one partnering meetings – with more than 25,000 of those sessions expected to take place at this year's meeting in Chicago – the gathering also is an opportunity for firms to rally together on regulatory and legislative issues facing the industry, while catching up on what the latest changes mean for their companies.